ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

DCT Concepts Approved

October 11, 1985

Artificial Neural Networks Predict Clinical Outcomes

November 26, 2004

NCI-Approved Clinical Trials

June 24, 2005

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

Bioassay Program To NIEHS” NCI Denies Rumor

March 31, 1978